tiprankstipranks

GB:3LAZ ETF Price & Analysis

Compare

3LAZ ETF Chart & Stats

ETF Overview

GraniteShares 3x Long Astrazeneca Daily ETP

GraniteShares 3x Long Astrazeneca Daily ETP (Ticker: GB:3LAZ) is a specialized Exchange Traded Product designed to deliver amplified exposure to the pharmaceutical sector, specifically focusing on the performance of AstraZeneca, a global leader in the healthcare industry. This ETP offers investors the opportunity to capitalize on AstraZeneca's daily market movements with a leveraged approach, aiming to provide three times the daily return of the company's stock. Ideal for sophisticated investors with a bullish outlook on AstraZeneca, this fund allows for strategic positioning within the pharmaceuticals niche of the healthcare sector. By harnessing the power of leverage, GB:3LAZ enables investors to potentially enhance returns from short-term price movements, while bearing in mind the associated risks of leveraged investments. This product is best suited for those who have a deep understanding of market dynamics and are looking to optimize their portfolio with targeted exposure to one of the largest pharmaceutical companies in the world.

GraniteShares 3x Long Astrazeneca Daily ETP (3LAZ) Fund Flow Chart

GraniteShares 3x Long Astrazeneca Daily ETP (3LAZ) 1 year Net Flows: 0

3LAZ ETF FAQ

What was GB:3LAZ’s price range in the past 12 months?
GB:3LAZ lowest ETF price was 1956.50 and its highest was 5800.00 in the past 12 months.
    What is the AUM of GB:3LAZ?
    As of Feb 20, 2025 The AUM of GB:3LAZ is 412.60K.
      Is GB:3LAZ overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does GB:3LAZ pay dividends?
      GB:3LAZ does not currently pay dividends.
      How many shares outstanding does GB:3LAZ have?
      Currently, no data Available
      Which hedge fund is a major shareholder of GB:3LAZ?
      Currently, no hedge funds are holding shares in GB:3LAZ
      Popular ETFs
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis